Sign In
Buy NVST
$22.40
-0.540 (-2.35%)
At Close: Jun 03, 2026
Is Envista (NVST) Stock Undervalued Right Now?
10:40am, Thursday, 02'nd Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
NVST or LZAGY: Which Is the Better Value Stock Right Now?
12:51pm, Wednesday, 01'st Jan 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Lonza Group Ag (LZAGY). But which of these two stocks presents investors with the be
Reasons to Retain Envista Stock in Your Portfolio for Now
07:46am, Thursday, 12'th Dec 2024
NVST's Specialty Products and Technologies business' strong performance appears promising. Yet, a leveraged balance sheet is worrisome.
Envista Announces Release of 2023 Sustainability Report
04:10pm, Wednesday, 20'th Nov 2024
BREA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2023 Sustainability Report, outlining its continued efforts to integrate envir
Envista Announces Participation in Evercore HealthCONx Conference
04:10pm, Tuesday, 19'th Nov 2024
BREA, Calif. , Nov. 19, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in a fireside chat at the Evercore HealthCONx Conf
Deciphering Envista (NVST) International Revenue Trends
10:22am, Monday, 04'th Nov 2024
Evaluate Envista's (NVST) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash
12:16pm, Thursday, 31'st Oct 2024
NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024.
Envista Holdings Corporation (NVST) Q3 2024 Earnings Conference Call Transcript
09:44pm, Wednesday, 30'th Oct 2024
Envista Holdings Corporation (NYSE:NVST ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Amit Bhagwat - VP of IR Paul Keel - CEO Eric Hammes - CFO Conference Call Pa
Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics
08:36pm, Wednesday, 30'th Oct 2024
Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Str
Envista (NVST) Q3 Earnings and Revenues Beat Estimates
06:51pm, Wednesday, 30'th Oct 2024
Envista (NVST) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.43 per share a year ago.
Envista Reports Third Quarter 2024 Results
04:10pm, Wednesday, 30'th Oct 2024
BREA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter of 2024.
Earnings Preview: Envista (NVST) Q3 Earnings Expected to Decline
11:07am, Wednesday, 23'rd Oct 2024
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envista Schedules Third Quarter 2024 Earnings Call
04:10pm, Monday, 07'th Oct 2024
BREA, Calif. , Oct. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2024 on Wednesday, October 30, 2024.
Envista Announces Participation in Baird's 2024 Global Healthcare Conference
04:10pm, Tuesday, 27'th Aug 2024
BREA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on W
Envista: $1.2 Billion Asset Impairments Was Fully Priced In
07:12am, Friday, 16'th Aug 2024
Envista Holdings Corporation published Q2 2024 earnings results, highlighting a $1.2 billion non-cash charge from impairments. I find their valuation metrics quite attractive, comparing favorably to b
